Feb 10, 2023
Jan 30, 2023
S1416 trial results show PARP inhibitor benefit in "BRCA-like" triple-negative breast cancer
Jan 27, 2023
Jan 20, 2023
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some
Jan 20, 2023
Jan 13, 2023
New (and renamed!) – exciting Hope programs with a focus on early-stage investigators
Dec 19, 2022
Four decades of NCI-funded NCTN trials gave U.S. patients 14.2 million life-years for a federal investment of $326 per life-year gained
Dec 16, 2022
14+ million years of life come from an astonishingly modest investment
Dec 9, 2022